EA201201198A2 - METHOD OF BRAKING GROWTH OF ELF CARCINOMA IN THE LABORATORY ANIMAL - Google Patents

METHOD OF BRAKING GROWTH OF ELF CARCINOMA IN THE LABORATORY ANIMAL

Info

Publication number
EA201201198A2
EA201201198A2 EA201201198A EA201201198A EA201201198A2 EA 201201198 A2 EA201201198 A2 EA 201201198A2 EA 201201198 A EA201201198 A EA 201201198A EA 201201198 A EA201201198 A EA 201201198A EA 201201198 A2 EA201201198 A2 EA 201201198A2
Authority
EA
Eurasian Patent Office
Prior art keywords
laboratory animal
carcinoma
elf
braking
growth
Prior art date
Application number
EA201201198A
Other languages
Russian (ru)
Other versions
EA201201198A3 (en
EA022546B1 (en
Inventor
Алексей Валерьевич Осипов
Татьяна Ильинична Терпинская
Владимир Сергеевич Улащик
Юрий Николаевич Уткин
Original Assignee
Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук
Государственное Научное Учреждение "Институт Физиологии Национальной Академии Наук Беларуси"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук, Государственное Научное Учреждение "Институт Физиологии Национальной Академии Наук Беларуси" filed Critical Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук
Publication of EA201201198A2 publication Critical patent/EA201201198A2/en
Publication of EA201201198A3 publication Critical patent/EA201201198A3/en
Publication of EA022546B1 publication Critical patent/EA022546B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине и биологии, к области экспериментальной онкологии и позволяет добиться торможения роста перевиваемой карциномы Эрлиха у лабораторного животного за счет внутрибрюшинного введения не обладающего повреждающим действием в отношении ДНК и мембран клеток водного раствора фактора роста нервов, полученного из змеиного яда.The invention relates to medicine and biology, to the field of experimental oncology and allows you to achieve growth inhibition of transplantable Ehrlich carcinoma in a laboratory animal due to intraperitoneal administration of an aqueous solution of nerve growth factor derived from snake venom without damaging effect on DNA and cell membranes.

EA201201198A 2011-09-28 2012-09-27 Method for inhibiting growth of ehrlich carcinoma in laboratory animal EA022546B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BY20111262 2011-09-28

Publications (3)

Publication Number Publication Date
EA201201198A2 true EA201201198A2 (en) 2013-03-29
EA201201198A3 EA201201198A3 (en) 2013-07-30
EA022546B1 EA022546B1 (en) 2016-01-29

Family

ID=47988444

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201201198A EA022546B1 (en) 2011-09-28 2012-09-27 Method for inhibiting growth of ehrlich carcinoma in laboratory animal

Country Status (1)

Country Link
EA (1) EA022546B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2774589C1 (en) * 2021-10-30 2022-06-21 Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации (ФГБУ «НМИЦ радиологии» Минздрава России) Method for carrying out photodynamic therapy of solid ehrlich carcinoma in mice

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5630997A (en) * 1979-08-24 1981-03-28 Toyama Chem Co Ltd Carcinostatic substance tf-120, its preparation, and carcinostatic comprizing it
CN100589839C (en) * 2003-01-28 2010-02-17 艾恩伍德医药品股份有限公司 Polypeptide and medicament composition containing polypeptide
EA011866B1 (en) * 2004-10-19 2009-06-30 Амджен Инк. Angiopoetin-2 specific binding agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2774589C1 (en) * 2021-10-30 2022-06-21 Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации (ФГБУ «НМИЦ радиологии» Минздрава России) Method for carrying out photodynamic therapy of solid ehrlich carcinoma in mice

Also Published As

Publication number Publication date
EA201201198A3 (en) 2013-07-30
EA022546B1 (en) 2016-01-29

Similar Documents

Publication Publication Date Title
IN2015DN01300A (en)
EA201991369A1 (en) MODIFIED RNA GUIDES
EA201391019A1 (en) CONNECTIONS AND METHODS FOR KINAZ MODULATION AND ALSO THE INDICATIONS TO THEIR APPLICATION
MX2016007541A (en) Modified nucleic acid molecules and uses thereof.
EA201500207A1 (en) HETEROAROMATIC COMPOUNDS AS VTK INHIBITORS
EA201401281A1 (en) D-AMINO ACID CHEMICAL COMPOUNDS FOR THE TREATMENT OF LIVER DISEASES
SG10201906673WA (en) Artificial nucleic acid molecules
CY1117858T1 (en) Oligonucleotides for the induction of a change in the sequence of a molecule-target RNA present in a living cell
DK3115457T3 (en) PROCEDURE FOR MODIFYING GENE SEQUENCE TO SPECIFICALLY CONVERT THE NUCLEIC ACID BASES OF TARGETED DNA SEQUENCE AND MOLECULAR COMPLEX TO USE IN SAME
EP3340925A4 (en) Blood pump controllers and methods of use for improved energy efficiency
BR112015016136A2 (en) methods to isolate microvesicles
DK3311827T3 (en) NANOPARTICLES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF AS CARRIERS FOR AMPHIPATHIC OR HYDROPHOBIC MOLECULES IN THE MEDICAL FIELD, INCLUDING CANCER TREATMENT, AS WELL AS FOOD-RELATED COMPOUNDS
EP3161160A4 (en) Methods of analyzing nucleic acids from individual cells or cell populations
TR201901939T4 (en) Antisense nucleic acid.
SG10201710631RA (en) Artificial nucleic acid molecules for improved protein or peptide expression
AR093377A1 (en) ANTI-NOTCH ANTIBODIES AND ANTIBODY-FARMACO CONJUGATES
EA201690529A1 (en) METHODS OF MODIFICATION OF CELL-HOST
BR112013018898A2 (en) treatment of autism spectrum disorders employing glycyl-1-2-methylprolyl-1-glutamic acid.
EP3368178A4 (en) Methods and systems for controlling dna, rna and other biological molecules passing through nanopores
DK3036320T3 (en) MANAGEMENT OF PROTEIN GLYCOSYLATION BY CULTIVATION MEDIA ADDITION AND CELL CULTURE PROCESS PARAMETERS
EA201301336A1 (en) TREATMENT OF CANCER BY THE COMBINATION OF DNA MOLECULES THINKING TWO-DEPLOYMENT DISTRIBUTIONS AND HYPERTHERMIA
IN2015DN02479A (en)
EP2569014A4 (en) Treatment methods
UY34371A (en) NUCLEIC ACID MOLECULES THAT ARE ADDRESSED TO RPS6 AND CONFERENCE RESISTANCE TO PATHOPHERAL PESTS.
WO2012158437A3 (en) Cannula apparatus and ventricular assist systems using the cannula apparatus

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU